The MicroRNA Landscape of MYCN-Amplified Neuroblastoma.

Misiak, Danny; Hagemann, Sven; Bell, Jessica L; Busch, Bianca; Lederer, Marcell; Bley, Nadine; Schulte, Johannes H; Hüttelmaier, Stefan

Misiak, Danny; Hagemann, Sven; Bell, Jessica L; Busch, Bianca; Lederer, Marcell; Bley, Nadine; Schulte, Johannes H; Hüttelmaier, Stefan.

Afiliación

Misiak D; Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany.
Hagemann S; Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany.
Bell JL; Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany.
Busch B; Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany.
Lederer M; Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany.
Bley N; Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany.
Schulte JH; Department of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Hüttelmaier S; German Consortium for Translational Cancer Research (DKTK), Partner Site Charité Berlin, Berlin, Germany.

Front Oncol ; 11: 647737, 2021.

Article en En | MEDLINE | ID: mdl-34026620

Palabras clave

IGF2BP1; MYCN; diagnostic marker; microRNAs; mir-17-92 cluster; neuroblastoma; pediatric cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: Alemania